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Airborne phthalate esters are present at
detectable levels across the surface of Earth.
They were ﬁrst identiﬁed in outdoor urban air
(Cautreels and Van Cauwenberghe 1976a,
1976b) and subsequently have been recognized
as global pollutants (Atlas and Giam 1981;
Giam et al. 1978) and major constituents of
indoor air (Weschler 1980, 1984). Their pres-
ence in outdoor and indoor environments
reﬂects their large emission rates coupled with
moderate atmospheric lifetimes. The total
global consumption of phthalate esters is esti-
mated to exceed 3.5 million metric tons/year,
with di(2-ethylhexyl) phthalate (DEHP) con-
stituting roughly 50% of the market share
(Cadogan and Howick 1996). Consumption of
di-n-butyl phthalate (DnBP) and n-butyl
benzyl (BBzP) phthalate is smaller but still
quite large (> 100,000 metric tons/year each)
(Cadogan and Howick 1996). Although
DEHP plasticizes numerous products, roughly
95% of the current production is used in
polyvinyl chloride (PVC) (National Toxicology
Program 2003), where it typically constitutes
30% of PVC by weight (Cadogan and Howick
1996; Kavlock et al. 2002b). DnBP is used in
latex adhesives, in nail polish and other cos-
metic products, as a plasticizer in cellulose plas-
tics, as a solvent for certain dyes, and, to a lesser
extent than DEHP, as a plasticizer in PVC
(Kavlock et al. 2002c). BBzP is a plasticizer for
vinyl tile, carpet tiles, and artificial leather
and is also used in certain adhesives (Kavlock
et al. 2002a).
Research groups have assessed the exposures
of various populations to phthalate esters by
using their metabolites in human urine as bio-
markers [Barr et al. 2003; Blount et al. 2000;
Centers for Disease Control and Prevention
(CDC) 2003; Koch et al. 2003]. The bio-
marker results translate to daily exposures for
DnBP, BBzP, and DEHP of 1.5, 0.88, and
0.71 µg/kg/day in the United States (Kohn
et al. 2000); 0.95, 0.71, and 0.84 µg/kg/day in
the United States (derived from data from Barr
et al. 2003, their Table 1, using the procedure
outlined by Kohn et al. 2000); and 5.22, 0.60,
and 13.8 µg/kg/day in Germany (Koch et al.
2003). These findings confirm the relatively
large daily exposure to phthalates in industrial-
ized countries. Although the dominant route
of exposure to DnBP, BBzP, and DEHP is
thought to be via ingestion (Fromme et al.
2004; Kavlock et al. 2002a, 2002b, 2002c),
few if any population-based data are available
to support this statement. Indeed, a recent
study has demonstrated associations between
phthalate concentrations in inhaled air and uri-
nary monoester metabolites (Adibi et al. 2003).
The incidence of asthma and allergy has
increased throughout the developed world
over the past 30 years (Beasley et al. 2003).
The short interval over which it has occurred
implies that the increase is caused by changes
in environmental exposures rather than genetic
changes (Etzel 2003; Strachan 2000). Changes
in indoor environments warrant special atten-
tion because indoor air constitutes a domi-
nant exposure route. Increased exposures to
allergens and/or adjuvants (enhancing factors)
may each be partially responsible for the
increase. Multidisciplinary reviews of the
scientific literature on associations between
indoor exposures and asthma and allergies
(Ahlbom et al. 1998; Andersson et al. 1997;
Bornehag et al. 2001; Schneider et al. 2003;
Wargocki et al. 2002) indicate that the
underlying causal factors responsible for these
increases remain unknown.
The use of plasticized products and, conse-
quently, exposures to phthalate esters have
increased dramatically since the end of World
War II. Phthalate esters have been suggested to
act as either allergens or adjuvants (Jaakkola
et al. 1999; Oie et al. 1997). Several recent
studies have examined the ability of different
phthalate esters to function as adjuvants in
BALB/c mice injected with a known antigen.
DEHP displayed an adjuvant effect with
immunoglobulin G1 at a concentration of
2,000 mg/mL after both one and two boosters
(Larsen et al. 2001b). In contrast, DnBP only
showed an adjuvant effect with immuno-
globulin G1 after the second booster (Larsen
et al. 2002), and BBzP showed no adjuvant
effect (Larsen et al. 2003). Consistent with
these results, the monoester of DEHP showed
an adjuvant effect whereas the monoesters of
DnBP and BBzP did not (Larsen et al. 2001a).
The present study is a nested case–
control study on 198 symptomatic children
and 202 healthy controls, including detailed
clinical examinations by physicians in parallel
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Global phthalate ester production has increased from very low levels at the end of World War II
to approximately 3.5 million metric tons/year. The aim of the present study was to investigate
potential associations between persistent allergic symptoms in children, which have increased
markedly in developed countries over the past three decades, and the concentration of phthalates
in dust collected from their homes. This investigation is a case–control study nested within a
cohort of 10,852 children. From the cohort, we selected 198 cases with persistent allergic symp-
toms and 202 controls without allergic symptoms. A clinical and a technical team investigated
each child and her or his environment. We found higher median concentrations of butyl benzyl
phthalate (BBzP) in dust among cases than among controls (0.15 vs. 0.12 mg/g dust). Analyzing
the case group by symptoms showed that BBzP was associated with rhinitis (p = 0.001) and eczema
(p = 0.001), whereas di(2-ethylhexyl) phthalate (DEHP) was associated with asthma (p = 0.022).
Furthermore, dose–response relationships for these associations are supported by trend analyses.
This study shows that phthalates, within the range of what is normally found in indoor environ-
ments, are associated with allergic symptoms in children. We believe that the different associations
of symptoms for the three major phthalates—BBzP, DEHP, and di-n-butyl phthalate—can be
explained by a combination of chemical physical properties and toxicologic potential. Given the
phthalate exposures of children worldwide, the results from this study of Swedish children have
global implications. Key words: allergy, asthma, BBzP, children, DEHP, homes, phthalates.
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http://dx.doi.org/ [Online 15 July 2004]with extensive inspections and measurements
within the subjects’ homes. The cases and
controls were selected from the first phase
(Dampness In Buildings and Health, phase I),
which was a cross-sectional questionnaire
soliciting health and environmental informa-
tion regarding all 14,077 children 1–6 years of
age in the county of Värmland, Sweden;
responses were obtained for 10,852 (Bornehag
et al. 2003).
The aim of the present study was to inves-
tigate potential associations between persis-
tent allergic symptoms in children and the
concentrations of different phthalates in dust
collected from their homes.
Materials and Methods
Inclusion criteria for cases and controls. The
selection criteria for the cases (Dampness In
Buildings and Health, phase II) were as fol-
lows: a) in the initial questionnaire, reports of
at least two incidents of eczema, or wheezing
or rhinitis without a cold, during the preced-
ing 12 months; and b) in the follow-up ques-
tionnaire 1.5 years later, at least two of three
possible symptoms reported. Inclusion criteria
for the controls were a) no symptoms in the
ﬁrst questionnaire and b) no symptoms in the
follow-up questionnaire. For both groups they
had to c) not have rebuilt their homes because
of moisture problems and d) not have changed
residence since the ﬁrst questionnaire. All chil-
dren with at least two symptoms in the first
questionnaire were invited to participate in the
case–control study (n = 1,056, corresponding
to 9.7% of the total population). In the ﬁrst
questionnaire, 5,303 (48.9%) reported no air-
way, eye, nose, or skin symptoms. Of these,
1,100 children were randomly selected and
invited to participate in the case–control study.
This process ultimately yielded 198 cases and
202 controls.
Families were more inclined to partici-
pate if the child was reported to have more
symptoms, if there was no smoking in the
family, and if they belonged to a higher
socioeconomic group.
Medical examination. The medical exami-
nation of the 400 children (3–8 years of age)
was performed during the same 2 weeks that
the technical investigations of the homes,
including dust collection, were carried out.
Medical doctors examined the children and
took a detailed history of each child. Blood
samples were drawn from 387 children and
screened for common allergens (Phadiatop,
Pharmacia & Upjohn Diagnostics, Uppsala,
Sweden), timothy, birch, mugworth, cat, horse,
dog, house dust mites (Dermatophagoides
pteronyssinus and Dermatophagoides farinae),
and one mold (Cladosporium).
Physicians’ diagnoses of the children agreed
well with the case–control status as reported in
the questionnaire. All children with obvious
asthma were found among cases, whereas
10 cases were found among controls (two chil-
dren with rhinitis and eight children with
eczema). Furthermore, 13 cases were found to
be misclassified. In the analyses regarding
case–control status, the study design has been
used; that is, the 23 (10 plus 13) misclassiﬁed
children have not been reclassiﬁed.
Building investigations. There were
10 pairs of siblings among the 400 children;
hence, they lived in 390 buildings. Between
October 2001 and April 2002, six professional
inspectors performed visual inspections and
indoor air quality assessments, including dust
sampling, in these 390 dwellings. During these
investigations, a preestablished checklist was
followed regarding building characteristics,
mold and water damages, surface materials,
and other building-related items.
Phthalates in dust. Samples of dust from
390 homes were collected from molding and
shelves in the children’s bedroom. The dust
was collected on 90-mm membrane ﬁlters in
holders made of styrene-acrylonitrile polymer
mounted on a sampler made of polypropylene
(VacuuMark disposable nozzle; Petersen Bach,
Bjerringbro, Denmark) connected to a vac-
uum cleaner. The filter was weighed before
and after sampling under controlled condi-
tions. Conditioning the ﬁlters before weighing
(23°C, 50% relative humidity) was critical to
obtaining reproducible filter weights. From
the 390 homes there were 9 missing samples,
13 samples with errors in the laboratory analy-
sis, and 6 samples with a negative dust weight.
Consequently, there were 362 valid samples.
Only filters with a reliably measurable net
increase in weight (≥ 25 mg) were included
in the present analysis; 346 of the 362 dust
samples met this criterion.
The dust samples were extracted in pre-
cleaned 10-mL glass vials for 30 min using
2 mL dichloromethane. This procedure was
repeated, and the two extracts were then com-
bined and transferred to 3-mL autosampler
vials. Aliquots from these vials were injected
into either a gas chromatograph/mass selective
detector (GC/MSD) for phthalate identifi-
cation or a GC/ﬂame ionization detector for
quantitation. GC was performed using a 25-m
capillary column (HP 1C; Agilent, Folsom,
CA, USA; inner diameter, 0.2 mm; stationary
phase, polydimethyl siloxane). The injector
temperature was 280°C; column temperature
started at 100°C for 3 min and then increased
at 8°C/min to 300°C, which was maintained
for 20 min. The detector temperature and
transfer line to the MSD were maintained at
280°C. The analytical and field sampling
techniques were tested in a preliminary study
that found only limited inﬂuence from back-
ground contributions to the analyzed samples.
In the present study, field blanks have indi-
cated no signiﬁcant background contributions.
The dust concentrations (milligram per gram
dust) of six phthalates were determined:
diethyl phthalate (DEP), diisobutyl phthalate
(DIBP), DnBP, BBzP, DEHP, and diisononyl
phthalate (DINP).
Statistical method. The concentrations of
phthalates in the dust were log-normally dis-
tributed. Hence, analyses of potential associa-
tions between concentrations of phthalates in
dust and health outcomes have been con-
ducted using nonparametric tests (Mann-
Whitney U-test). Log-transformed, normally
distributed concentrations were tested with
parametric tests (t-test). The concentrations
are reported as medians, as arithmetic means,
and as geometric means with 95% conﬁdence
intervals (CIs). The CIs were calculated with
a back-transform of mean log ± 2 × SE.
Dose–response relationships were tested by
factoring the phthalate concentrations into
quartiles and using both uni- and multivariate
logistic regression analyses. Adjustments have
been made for environmental tobacco smoke
as well as sex and age of the child, because
these have been associated with asthma and
allergic symptoms. Adjustments for type of
building were made, because living in a
privately owned single-family house was a
selection factor for both cases and controls
(Bornehag et al., unpublished data). Indeed,
cases and controls lived mainly in single-
family houses (88.7%). Furthermore, the fre-
quency of PVC as ﬂooring material was lower
in single-family houses than in multifamily
houses (51.6 vs. 71.8%). Adjustments for the
construction period of the building and self-
reported water leakage in the home during
the previous 3 years were made because these
are associated with the concentrations of
phthalates in dust. Finally, adjustments were
made for exposure to other phthalates.
Multiple logistic regressions were performed
by a backward elimination technique where
only signiﬁcant variables were included in the
final model. The analyses were considered
statistically signiﬁcant when p < 0.05.
The study was approved by the local
ethics committee.
Results
Compared with other types of ﬂooring materi-
als, PVC ﬂooring in the child’s bedroom was
positively associated with case status [adjusted
odds ratio (OR), 1.59; 95% CI, 1.05–2.41].
Phthalates in dust. Results are presented in
Tables 1–3 and Figure 1. In Tables 1 and 2,
median phthalate dust concentrations are
reported for data sets that include all valid
samples with a reliably measurable net
increase in weight (346 of 390 homes), and
geometric mean concentrations are reported
for data sets that exclude samples with phtha-
late dust concentrations less than the detec-
tion limit. (If, instead, nondetects were
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tion limit, then for phthalates with a large
number of nondetects, their dust concentra-
tions would no longer be log-normally dis-
tributed.) The geometric mean concentrations
of BBzP and DEHP were higher in bedrooms
with PVC ﬂooring than in bedrooms without
such ﬂooring [BBzP: 0.208 (n = 164) vs. 0.147
(n = 107) mg/g dust; DEHP: 0.994 (n = 186)
vs. 0.638 (n = 155) mg/g dust; both p < 0.001
by t-test]. DEP, DIBP, DnBP, and DINP
were not associated with PVC ﬂooring.
Association between phthalates in dust
and health effects. Cases had a higher concen-
trations of BBzP in the dust samples from the
children’s bedrooms than did the controls in
parametric as well as in nonparametric tests
(Table 1). Cases with physician-diagnosed
rhinitis or eczema had higher BBzP concen-
trations in the bedroom dust compared with
controls (Table 2). Furthermore, cases with
doctor-diagnosed asthma had higher DEHP
concentrations in the dust compared with
controls. In analyses restricted to single-family
and row houses, the same associations were
found (data not shown).
In an analysis restricted to homes with PVC
ﬂooring in the child’s bedroom (n = 189), the
median BBzP concentration was signiﬁcantly
higher among cases compared with controls
(0.21 vs. 0.16 mg/g dust, respectively; Mann-
Whitney U-test, p = 0.042), and BBzP was
associated with rhinitis and eczema (Table 2).
Such differences between cases and controls
were not observed for DEHP.
BBzP concentrations in the highest quar-
tile were associated with an increased risk of
being a “case child” (Table 3). The same asso-
ciation was found after adjusting for possible
confounders. Table 3 also shows associations
between phthalates in dust and doctor-diag-
nosed asthma, rhinitis, or eczema. A dose–
response relationship was found between con-
centrations of BBzP in dust and doctor-diag-
nosed rhinitis and eczema in both crude and
adjusted analyses. For DEHP, a dose–response
relationship was found for asthma in both
crude and adjusted analyses, as well as in
analysis restricted to single-family houses (data
not shown for the latter).
Specific immunoglobulin E in blood.
Figure 1 presents the concentration of phtha-
lates in dust among cases and controls with
and without specific immunoglobulin E
in blood (i.e., atopics and nonatopics).
Within the group of cases, the highest geo-
metric mean concentrations of BBzP were
found in dust from the bedrooms of atopics.
However, when comparing cases with and
without atopy, the difference was not statisti-
cally signiﬁcant (p = 0.564).
Discussion
In the present study we found associations
between dust concentrations of specific
phthalate esters and asthma, rhinitis, and
eczema. As shown in Tables 2 and 3, BBzP is
signiﬁcantly associated with doctor-diagnosed
rhinitis and eczema, whereas DEHP is sig-
nificantly associated with doctor-diagnosed
asthma. Interestingly, no such associations are
found for DnBP despite the fact that the
median concentrations of BBzP and DnBP in
the settled dust were comparable (0.150 vs.
0.135 mg/g; Table 1). Hence, these three
phthalates display strikingly different associa-
tions between their dust concentrations and
the health outcomes monitored in this study.
From a physical chemistry viewpoint, DnBP,
BBzP, and DEHP are significantly different
from one another; they possess different vapor
pressures, polarities, water solubilities, and
octanol/air partition coefficients. For exam-
ple, the vapor pressures of DnBP and BBzP
are two orders of magnitude greater than that
of DEHP. This means that greater fractions
of DnBP and BBzP are in the gas phase as
Children’s Health | Phthalate exposure indoors and allergic symptoms
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Table 2. Concentration of phthalates (BBzP and DEHP) in surface dust for case children with a doctor-diagnosed disease compared with controls.
Casesa Controls Cases Controls
Median conc Median conc U-testb GM conc GM conc t-Testc
Phthalate Disease No. (mg/g dust) No. (mg/g dust) (p-value) No. [(95% CI) mg/g dust] No. [(95% CI) mg/g dust] (p-value)
All homes
BBzP Asthma 106 0.152 177 0.118 0.064 82 0.219 (0.177–0.270) 137 0.157 (0.139–0.178) 0.005
Rhinitis 79 0.181 177 0.118 0.007 65 0.237 (0.185–0.304) 137 0.157 (0.139–0.178) 0.001
Eczema 115 0.181 177 0.118 0.001 95 0.224 (0.186–0.269) 137 0.157 (0.139–0.178) 0.001
DEHP Asthma 106 0.899 177 0.723 0.008 106 0.966 (0.807–1.156) 176 0.741 (0.643–0.855) 0.022
Rhinitis 79 0.783 177 0.723 0.383 78 0.811 (0.638–1.030) 176 0.741 (0.643–0.855) 0.510
Eczema 115 0.844 177 0.723 0.111 115 0.855 (0.721–1.014) 176 0.741 (0.643–0.855) 0.207
Homes with PVC ﬂooring
in the child’s bedroom
BBzP Asthma 59 0.195 82 0.159 0.168 52 0.237 (0.177–0.316) 71 0.177 (0.148–0.212) 0.076
Rhinitis 45 0.216 82 0.159 0.008 43 0.265 (0.192–0.366) 71 0.177 (0.148–0.212) 0.018
Eczema 70 0.216 82 0.159 0.003 66 0.257 (0.204–0.324) 71 0.177 (0.148–0.212) 0.011
DEHP Asthma 59 1.006 82 0.855 0.149 59 1.148 (0.904–1.459) 82 0.938 (0.752–1.169) 0.228
Rhinitis 45 0.792 82 0.855 0.924 44 1.040 (0.771–1.403) 82 0.938 (0.752–1.169) 0.586
Eczema 70 0.904 82 0.855 0.379 70 1.045 (0.845–1.291) 82 0.938 (0.752–1.169) 0.491
Abbreviations: conc, concentration; GM, geometric mean.
aCases with doctor diagnosed disease (asthma, rhinitis, or eczema). b Mann-Whitney U-test.cTest of the difference between cases and controls made on mean log-transformed concentration.
Table 1. Concentrations of phthalates in surface dust from children’s bedrooms.
Median (arithmetic mean) concentration
of phthalates (mg/g dust) All Cases Controls
No. of All samples Cases Controls U-testc No. of samples GM conc GM conc t-Teste
Phthalate homesa (n = 346) (n = 175)b (n = 177)b (p-value) homesd GM conc No. [(95% CI) mg/g dust] No. [(95% CI) mg/g dust] (p-value)
DEP 346 0.000 (0.031) 0.000 (0.046) 0.000 (0.018) 0.628 47 0.073 22 0.102 (0.049–0.211) 26 0.058 (0.035–0.097) 0.200
DIBP 346 0.045 (0.097) 0.042 (0.102) 0.048 (0.092) 0.424 290 0.056 141 0.058 (0.048–0.070) 154 0.055 (0.046–0.065) 0.635
DnBP 346 0.150 (0.226) 0.150 (0.228) 0.149 (0.220) 0.914 308 0.174 158 0.171 (0.152–0.193) 154 0.178 (0.157–0.201) 0.639
BBzP 346 0.135 (0.319) 0.152 (0.472) 0.118 (0.163) 0.014 272 0.181 139 0.209 (0.180–0.244) 137 0.157 (0.139–0.178) 0.004
DEHP 346 0.770 (1.310) 0.828 (1.384) 0.723 (1.229) 0.160 343 0.789 173 0.836 (0.724–0.964) 176 0.741 (0.643–0.855) 0.232
DINP 346 0.041 (0.639) 0.000 (0.671) 0.047 (0.589) 0.848 175 0.451 87 0.453 (0.352–0.583) 90 0.446 (0.351–0.566) 0.925
Abbreviations: conc, concentration; GM, geometric mean.
aNumber of homes with a dust sample weight > 25 mg. bThe sum of cases and controls is 352 because, among the 346 bedrooms, there were six bedrooms shared by siblings. cMann-
Whitney U-test. dNumber of homes with a dust sample weight > 25 mg and a phthalate concentration greater than the detection limit (0.040 mg/g dust for DnBP, BBzP, and DEHP). eTest
of the difference between cases and controls made on mean log-transformed concentration.opposed to the condensed phase (i.e., associ-
ated with dust and airborne particles). We
estimate that, for a particle concentration of
20 µg/m3, > 80% of airborne DnBP and
> 80% of airborne BBzP are in the gas phase,
whereas > 85% of airborne DEHP is associ-
ated with airborne particles (Weschler 2003).
The deposition of a compound in the respira-
tory tract is strongly inﬂuenced by whether it
is present in the gas phase or associated with
airborne particles. Furthermore, as a conse-
quence of their inherent chemical differences,
DnBP, BBzP, and DEHP, as well as their
monoester metabolites, produce different
effects in a mouse model (Larsen et al. 2001a,
2001b, 2002, 2003). Furthermore, each of
these phthalates has its distinct human meta-
bolic pathway (Barr et al. 2003). We suspect
that the different relative distributions between
the gas and condensed phases, coupled with
different toxicologic and pharmacokinetic
behaviors, contribute to the fact that DnBP,
BBzP, and DEHP are associated with different
health outcomes (i.e., DnBP, no associations;
BBzP, skin and mucosa symptoms; DEHP,
lower airway symptoms).
In the present study there is a general asso-
ciation between PVC ﬂooring and case status
(OR, 1.59). Both BBzP and DEHP correlate
with the amount of PVC ﬂooring in the sub-
jects’ homes. However, these two phthalates
are not associated with health effects simply
because they are associated with PVC ﬂooring.
This conclusion is supported by a number
of observations: First, specific associations
between BBzP and DEHP dust concentra-
tions and doctor-diagnosed diseases (Table 3)
are more pronounced than associations
between PVC flooring and such diseases.
Second, although BBzP and DEHP dust con-
centrations do correlate, the correlation is
weak (R = 0.52), and they are associated with
different health effects. Third, in a restricted
analysis, including only homes with PVC
ﬂooring, higher concentrations of BBzP were
found in dust from case homes than in that
from control homes.
The reported concentrations of phthalates
in the bedroom dust (Table 1) are consistent
with those reported in other studies. In dust
samples from 120 U.S. homes located on Cape
Cod, Massachusetts (Rudel et al. 2003), the
median concentrations were 0.34, 0.045, and
0.020 mg/g dust for DEHP, BBzP, and
DnBP, respectively. In a study of 59 apart-
ments in Berlin, Germany (Fromme et al.
2004), the median concentrations were 0.70,
0.030, and 0.047 mg/g dust for DEHP, BBzP,
and DnBP. Clausen et al. (2003) measured
mean DEHP concentrations of 3.2 mg/g dust
in 15 Danish schools and 0.86 mg/g dust for
23 Danish homes. Oie et al. (1997) reported
mean concentrations of 0.64 mg DEHP/g dust
and 0.11 mg BBzP/g dust for 38 homes in
Norway. Pohner et al. (1997) reported a 95th
percentile DEHP concentration of 2.0 mg/g
dust for 272 German homes, whereas another
German study on 286 homes reported a 95th
percentile DEHP concentration of 2.6 mg/g
dust (Butte et al. 2001).
Regarding atopic status and its association
with phthalate dust concentrations, the cho-
sen study design is not optimal. Because there
were only 16 atopic controls, the power of the
analysis on atopic children is limited. On the
other hand, our ﬁndings could be interpreted
to mean that the mechanism is of a non-
immunologic nature (e.g., exposure increases
the risk for irritation).
To identify potential selection biases
in the study group, we obtained information
for all invited families from the first cross-
sectional questionnaire. This revealed that the
final study group contained significantly
more single-family houses than the eligible
population. Adjusting and restricting the
analyses have addressed this problem. There
was no selection bias regarding PVC ﬂooring
because included and nonincluded cases and
controls reported about the same frequency
of occurrence of PVC flooring in the child’s
bedroom (Bornehag et al., unpublished data).
Furthermore, 10 controls and 13 cases were
misclassified when comparing self-reported
symptoms and doctors diagnoses. However,
when these children were excluded from the
analyses, the reported associations remained.
Finally, to be included as a “case,” a child
was required to have at least two symptoms.
Consequently, this study was not fine-tuned
to examine associations between building fac-
tors and single symptoms (i.e., asthma, rhini-
tis, or eczema). However, even if the design is
suboptimal, meaning it was more difﬁcult to
find associations between single symptoms
and exposures, the association between
selected building factors and single symptoms
is meaningful and possibly underestimates
true associations.
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Table 3. Crude and adjusted ORs (95% CIs) between phthalates (BBzP and DEHP) in surface dust and case
status or doctor-diagnosed disease.
Quartile
Groupa 1 (ref; n = 88) 2 (n = 88) 3 (n = 88) 4 (n = 88) p-Valueb
BBzP
Ranges (mg BBzP/g dust) 0.00–0.05 0.05–0.13 0.13–0.25 0.25–45.55
Crude analysis
Case status 1.0 0.69 (0.38–1.26) 1.00 (0.55–1.81) 2.01 (1.10–3.69) 0.012
Asthma 1.0 0.63 (0.31–1.27) 0.59 (0.45–1.76) 1.92 (0.98–3.79) 0.039
Rhinitis 1.0 0.85 (0.38–1.89) 1.12 (0.51–2.47) 2.69 (1.26–5.76) 0.006
Eczema 1.0 0.74 (0.36–1.52) 1.44 (0.73–2.81) 2.52 (1.26–5.00) 0.002
Adjustedc analysis
Case status 1.0 0.77 (0.40–1.46) 1.01 (0.53–1.90) 1.95 (1.02–3.74) —
Asthma 1.0 0.67 (0.33–1.38) 0.88 (0.43–1.80) 1.87 (0.92–3.81) —
Rhinitis 1.0 1.03 (0.44–2.39) 1.23 (0.53–2.88) 3.04 (1.34–6.89) —
Eczema 1.0 0.84 (0.40–1.76) 1.45 (0.71–2.97) 2.56 (1.24–5.32) —
DEHP
Ranges (mg DEHP/g dust) 0.00–0.46 0.46–0.77 0.77–1.30 1.30–40.46
Crude analysis
Case status 1.0 0.91 (0.50–1.65) 1.05 (0.58–1.89) 1.44 (0.80–2.61) 0.199
Asthma 1.0 1.11 (0.53–2.31) 1.51 (0.74–3.07) 2.36 (1.17–4.75) 0.009
Rhinitis 1.0 1.12 (0.53–2.36) 0.96 (0.44–2.11) 1.55 (0.73–3.28) 0.331
Eczema 1.0 1.00 (0.50–1.97) 1.35 (0.70–2.62) 1.50 (0.76–2.96) 0.161
Adjustedc analysis
Case status 1.0 NS NS NS —
Asthma 1.0 1.56 (0.70–3.46) 2.05 (0.94–4.47) 2.93 (1.36–6.34) —
Rhinitis 1.0 NS NS NS —
Eczema 1.0 NS NS NS —
—, no analyses have been done because linear-by-linear association cannot be done in a multivariate manner; NS, not
signiﬁcant in model, using backward elimination; ref, reference.
aCase status and subgroups with asthma, rhinitis, or eczema compared with controls. bLinear-by-linear association.
cAdjustments made for sex, age, smoking at home, type of building, construction period, self-reported ﬂooding during pre-
ceding 3 years, and the other phthalate variable (in quartiles), using backward elimination method; only signiﬁcant variables
were included in the ﬁnal model.
Figure 1. Geometric mean concentrations (95% CIs) of
phthalates (A), BBzP, and (B), DEHP in surface dust
from bedrooms of nonatopic and atopic children.
■
■
■ ■
■ ■
■
■The reported analyses are based on samples
with a weight > 25 mg. However, when includ-
ing all samples (n = 362), the reported asso-
ciations between exposure and symptoms
remained or became stronger (data not shown).
Koo et al. (2002) present weak associations
between exposure estimates for different phtha-
late esters, based on their urinary biomarkers,
and the level of education, family income, and
residency (urban or rural) in a reference U.S.
population. Given that study, one might spec-
ulate that the associations reported in the pre-
sent study are driven by demographic factors.
However, in contrast to the United States,
where 22.4% of the children live in households
with incomes < 50% of the national median,
in Sweden only 2.6% of the children live in
such households (Unicef 2000). Additionally,
the association in our study holds when the
analysis is restricted to single-family houses;
such homes have an even more homogeneous
socioeconomic status. Hence, different demo-
graphic factors between cases and controls
appear to be an unlikely explanation for the
associations observed in the present study.
Furthermore, given that the dust concentra-
tions of DnBP, BBzP, and DEHP display
quite different associations with different
symptoms, the associations reflect a biologic
response rather than just lifestyle or demo-
graphic factors associated with an increased use
of plasticized materials.
This study demonstrates associations
between BBzP and DEHP concentrations in
dust and selected allergies and asthma.
Although multiple factors likely are responsi-
ble for the increases in allergies and asthma
that have been documented in developed
countries over the past 30 years, it is striking
that these increases have occurred during a
period when plasticized products have
become ubiquitous in the homes, schools,
and workplaces of the developed world.
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